Adicet Bio, Inc. (NASDAQ:ACET) Receives $14.50 Consensus Price Target from Analysts
Shares of Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) have earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month […]
More Stories
StockNews.com Downgrades Brightcove (NASDAQ:BCOV) to Buy
StockNews.com cut shares of Brightcove (NASDAQ:BCOV – Free Report) from a strong-buy rating to a buy rating in a research...
StockNews.com Upgrades Team (NYSE:TISI) to “Strong-Buy”
StockNews.com upgraded shares of Team (NYSE:TISI – Free Report) from a buy rating to a strong-buy rating in a research...
Chicago Rivet & Machine (NYSEAMERICAN:CVR) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Chicago Rivet & Machine (NYSEAMERICAN:CVR – Free Report) in a report published on Wednesday...
Aeries Technology (AERT) & Its Competitors Head-To-Head Comparison
Profitability This table compares Aeries Technology and its peers’ net margins, return on equity and return on assets. Net Margins...
Insider Selling: Secure Energy Services Inc. (TSE:SES) Insider Sells 2,995 Shares of Stock
Secure Energy Services Inc. (TSE:SES – Get Free Report) insider David Bonderman sold 2,995 shares of the company’s stock in...
Tensions Rise Over ICC Arrest Warrants for Netanyahu, Gallant as US Allies Mull Response
By Tom Ozimek Controversy is intensifying and the stakes are rising over the International Criminal Court’s (ICC) recent decision to...